AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6404174 — intervention group
Group type: COMPARATOR
Intervention: thiotepa plus methotrexate
Number of subjects: 273
Study 6404174 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin plus cyclophosphamide
Number of subjects: 273
Study 6404174 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin plus Adriamycin
Number of subjects: 273
Study 6404174 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin plus hexamethylmelamine
Number of subjects: 273
Study 6404174 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin plus thiotepa
Number of subjects: 273
Study 30753996 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' PTSD symptoms
Number of subjects: 150
Study 30753996 — intervention group
Group type: EXPERIMENTAL
Intervention: Fathers' PTSD symptoms
Number of subjects: 150
Study 30753996 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' own PTSD symptoms
Number of subjects: 150
Study 30753996 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners' PTSD symptoms
Number of subjects: 150
Study 30753996 — intervention group
Group type: EXPERIMENTAL
Intervention: Interparental conflict
Number of subjects: 150
Study 30287602 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive case management intervention for up to 24 weeks
Number of subjects: 0
Study 30287602 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidelity of the case management intervention
Number of subjects: 0
Study 27025164 — intervention group
Group type: EXPERIMENTAL
Intervention: Open masks
Number of subjects: 50
Study 27025164 — intervention group
Group type: COMPARATOR
Intervention: Closed masks
Number of subjects: 50
Study 24149990 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream phonophoresis (2.5 % lidocaine, 2.5 % prilocaine)
Number of subjects: 50
Study 24149990 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound therapy
Number of subjects: 50
Study 23180067 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 0
Study 23180067 — intervention group
Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 0
Study 21073760 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-Emotional Technique (NET)
Number of subjects: 102
Study 21073760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 18674741 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg orally thrice a day for 3 months)
Number of subjects: 36
Study 18674741 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 36
Study 18674741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 15920180 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 3.0 microg/kg
Number of subjects: 64
Study 15920180 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol/remifentanil
Number of subjects: 64
Study 15920180 — intervention group
Group type: COMPARATOR
Intervention: propofol/succinylcholine
Number of subjects: 64
Study 12876173 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuliser hood
Number of subjects: 14
Study 12876173 — intervention group
Group type: COMPARATOR
Intervention: SVN plus mask
Number of subjects: 14
Study 10383539 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressurized aerosol 800 microg
Number of subjects: 16
Study 10383539 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous pump spray 400 microg
Number of subjects: 16
Study 10383539 — intervention group
Group type: EXPERIMENTAL
Intervention: Powder 800 microg
Number of subjects: 16
Study 9345419 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 MIU intramuscular recombinant interferon alpha‐2a (rIFNA) (Roferon‐A, Roche) (n = 12)
Number of subjects: 20
Study 9345419 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 20
Study 9345419 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFNA treatment
Number of subjects: 20
Study 1867894 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program emphasizing development of tactile skills using silicone breast models
Number of subjects: 89
Study 1867894 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 89
Study 1867894 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group training
Number of subjects: 89
Study 1867894 — intervention group
Group type: COMPARATOR
Intervention: Subset of experimental and control physicians' medical records
Number of subjects: 89
Study 6349262 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 0
Study 6349262 — intervention group
Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 0
Study 30206708 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey mouthwash
Number of subjects: 53
Study 30206708 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study 28246067 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based direct recruitment approach (patient-centric, PC)
Number of subjects: 64
Study 28246067 — intervention group
Group type: COMPARATOR
Intervention: Center of excellence (CoE) recruitment
Number of subjects: 64
Study 26314746 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time knowledge of performance (KP) feedback
Number of subjects: 5
Study 26314746 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic cueing in the form of knowledge of results (KR) feedback
Number of subjects: 5
Study 26314746 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control)
Number of subjects: 5
Study 24717258 — intervention group
Group type: EXPERIMENTAL
Intervention: VPA + memantine (5 mg/d)
Number of subjects: 214
Study 24717258 — intervention group
Group type: COMPARATOR
Intervention: VPA + placebo
Number of subjects: 214
Study 22197753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory interference task
Number of subjects: 105
Study 22197753 — intervention group
Group type: COMPARATOR
Intervention: No interference task
Number of subjects: 105
Study 22197753 — intervention group
Group type: COMPARATOR
Intervention: Conceptual interference task
Number of subjects: 105
Study 20598142 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of three medium hardboiled eggs
Number of subjects: 40
Study 20598142 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of egg substitute for 6 weeks
Number of subjects: 40
Study 20598142 — intervention group
Group type: COMPARATOR
Intervention: Sausage/cheese breakfast sandwich
Number of subjects: 40
Study 19034103 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 microg/kg)
Number of subjects: 2488
Study 19034103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2488
Study 15910128 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial order reconstruction task with varying path characteristics (path crossing, path length, angles)
Number of subjects: 0
Study 15910128 — intervention group
Group type: COMPARATOR
Intervention: Visuospatial order reconstruction task
Number of subjects: 0
Study 12454298 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose prednisolone and continuous nebulised salbutamol (US regimen)
Number of subjects: 170
Study 12454298 — intervention group
Group type: COMPARATOR
Intervention: Lower dose prednisolone and bolus nebulised salbutamol (UK regimen)
Number of subjects: 170
Study 10511066 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascending dosing pattern of methylphenidate
Number of subjects: 0
Study 10511066 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily dosing pattern of methylphenidate
Number of subjects: 0
Study 10511066 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat dosing pattern of methylphenidate
Number of subjects: 0
Study 10511066 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-times-a-day regimens of methylphenidate
Number of subjects: 0
Study 8476617 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml of 0.25% bupivacaine with epinephrine (0.5 mg per 100 ml of solution)
Number of subjects: 18
Study 8476617 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 0.5% bupivacaine with epinephrine (0.5 mg per 100 ml of solution)
Number of subjects: 18
Study 8476617 — intervention group
Group type: COMPARATOR
Intervention: Both groups (40 ml of 0.25% bupivacaine and 20 ml of 0.5% bupivacaine)
Number of subjects: 18
Study 3540875 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-caffeine-codeine-butalbital combination
Number of subjects: 0
Study 3540875 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen-codeine combination
Number of subjects: 0
Study 3540875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30337315 — intervention group
Group type: EXPERIMENTAL
Intervention: Aussie-FIT intervention (12 weekly 90 min workshops)
Number of subjects: 120
Study 30337315 — intervention group
Group type: COMPARATOR
Intervention: Waitlist comparison group
Number of subjects: 120
Study 27711094 — intervention group
Group type: EXPERIMENTAL
Intervention: URS
Number of subjects: 65
Study 27711094 — intervention group
Group type: COMPARATOR
Intervention: SWL
Number of subjects: 65
Study 26081224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fish (canned salmon + albacore)
Number of subjects: 25
Study 26081224 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA capsules
Number of subjects: 25
Study 26081224 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 25
Study 26081224 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dietary fish and n-3 PUFA capsules)
Number of subjects: 25
Study 26081224 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish arm
Number of subjects: 25
Study 24194642 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone long-acting injection (LAI) plus COMPASS (COMprehensive Psycho‐educational Approach and Scheme Set)
Number of subjects: 96
Study 24194642 — intervention group
Group type: COMPARATOR
Intervention: Risperidone long-acting injection (LAI) alone (control group)
Number of subjects: 96
Study 24194642 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone LAI plus COMPASS
Number of subjects: 96
Study 21448219 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk drink (Yacult) consumed daily for 28 days
Number of subjects: 28
Study 21448219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic food or drink)
Number of subjects: 28
Study 18567895 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF/ICSI with Preimplantation Genetic Screening (PGS)
Number of subjects: 0
Study 18567895 — intervention group
Group type: COMPARATOR
Intervention: IVF/ICSI without Preimplantation Genetic Screening (PGS)
Number of subjects: 0
Study 16866595 — intervention group
Group type: EXPERIMENTAL
Intervention: Response reversal task with 2 reward‐punishment contingencies (100‐0 and 80‐20)
Number of subjects: 0
Study 12627043 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.1 mg/day for 3 days
Number of subjects: 20
Study 12627043 — intervention group
Group type: COMPARATOR
Intervention: Estrogen withdrawal after long-term ERT
Number of subjects: 20
Study 10834770 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with autism
Number of subjects: 39
Study 10834770 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with developmental delays
Number of subjects: 39
Study 10834770 — intervention group
Group type: COMPARATOR
Intervention: Typically developing children
Number of subjects: 39
Study 9987969 — intervention group
Group type: EXPERIMENTAL
Intervention: psychotherapy with biofeedback + hypotensive drugs
Number of subjects: 85
Study 9987969 — intervention group
Group type: COMPARATOR
Intervention: hypotensive drugs only
Number of subjects: 85
Study 7835550 — intervention group
Group type: EXPERIMENTAL
Intervention: Borderline essential hypertension subjects
Number of subjects: 59
Study 7835550 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (reduced nocturnal blood pressure fall)
Number of subjects: 59
Study 7835550 — intervention group
Group type: COMPARATOR
Intervention: White coat hypertension subjects
Number of subjects: 59
Study 3042011 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant alpha‐interferon (rIFN‐alpha 2a2) in combination with etretinate
Number of subjects: 11
Study 3042011 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant alpha‐interferon (rIFN‐alpha 2a2) alone
Number of subjects: 11
Study 3042011 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (rIFN-alpha 2a2 + etretinate)
Number of subjects: 11
Study 3042011 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN-alpha 2a alone
Number of subjects: 11
Study 29569019 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath VOC biomarkers analyzed with gas chromatography mass spectrometry (GC MS)
Number of subjects: 178
Study 29569019 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath VOC biomarkers analyzed with surface acoustic wave detection (GC SAW)
Number of subjects: 178
Study 29569019 — intervention group
Group type: EXPERIMENTAL
Intervention: Low DF value
Number of subjects: 178
Study 29569019 — intervention group
Group type: EXPERIMENTAL
Intervention: High DF value
Number of subjects: 178
Study 29141055 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,064 nm laser treatment (5 monthly treatments)
Number of subjects: 27
Study 29141055 — intervention group
Group type: EXPERIMENTAL
Intervention: 532 nm laser treatment (4 monthly treatments)
Number of subjects: 27
Study 29141055 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 27
Study 26065915 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimney woodstove intervention (early stove households)
Number of subjects: 306
Study 26065915 — intervention group
Group type: COMPARATOR
Intervention: Delayed stove households (control)
Number of subjects: 306
Study 23920036 — intervention group
Group type: EXPERIMENTAL
Intervention: Laquinimod
Number of subjects: 0
Study 23920036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20331373 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ultrasound (3 MHz, 1.4 W/cm², 5 min, circular motion)
Number of subjects: 26
Study 20331373 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound (ultrasound not turned on)
Number of subjects: 26
Study 20331373 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ultrasound (over 2 weeks)
Number of subjects: 26
Study 20331373 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound (over 2 weeks)
Number of subjects: 26
Study 18248658 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg amitriptyline daily
Number of subjects: 54
Study 18248658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 16788419 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction of the TM with perichondrium/cartilage graft and intraoperative T-tube insertion
Number of subjects: 46
Study 16788419 — intervention group
Group type: COMPARATOR
Intervention: Reconstruction of the TM with perichondrium/cartilage graft without ventilation tube insertion
Number of subjects: 46
Study 14639153 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 94
Study 14639153 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 94
Study 10869928 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (Methylprednisolone)
Number of subjects: 0
Study 8619207 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (150 IU/kg body weight, subcutaneously every 2 days for 10 days before operation until postoperative day 2)
Number of subjects: 30
Study 8619207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 1402311 — intervention group
Group type: EXPERIMENTAL
Intervention: Water soluble contrast enemas performed in the early postoperative period (mean: day 7 postoperatively, range: days 4‐14)
Number of subjects: 233
Study 3922471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine enterocoated with cellulose acetate phthalate
Number of subjects: 14
Study 3922471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31489588 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus best supportive care (BSC)
Number of subjects: 0
Study 31489588 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 0
Study 29272606 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking after a high-carbohydrate/low-fat meal
Number of subjects: 0
Study 29272606 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 0
Study 26724564 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG)
Number of subjects: 0
Study 26724564 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual Group (CAUG)
Number of subjects: 0
Study 26724564 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG) with high quality care environments
Number of subjects: 0
Study 25211369 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor and acetylsalicylic acid (ASA) in combination with dabigatran (150 mg bid)
Number of subjects: 60
Study 25211369 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor and acetylsalicylic acid (ASA) in combination with rivaroxaban (20 mg od)
Number of subjects: 60
Study 25211369 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor and acetylsalicylic acid (ASA) in combination with phenprocoumon (INR 2.0‐3.0)
Number of subjects: 60
Study 22920810 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic games (exercise themed jogging)
Number of subjects: 100
Study 22920810 — intervention group
Group type: COMPARATOR
Intervention: Balance games (game themed)
Number of subjects: 100
Study 22920810 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic games (hula hooping)
Number of subjects: 100
Study 22920810 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic games (jogging)
Number of subjects: 100
Study 19414203 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG) with elevated HbA1c and waist circumference (WC) values
Number of subjects: 2603
Study 19414203 — intervention group
Group type: COMPARATOR
Intervention: Normal fasting glucose (NFG) with normal HbA1c and waist circumference (WC) values
Number of subjects: 2603
Study 17627484 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg nightly for 4 weeks)
Number of subjects: 10
Study 17627484 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identically appearing tablet nightly for 4 weeks)
Number of subjects: 10
Study 16235184 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-weekly trimethoprim-sulfamethoxazole (TS) for 12 weeks
Number of subjects: 240
Study 16235184 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (Control)
Number of subjects: 240
Study 11925400 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst culture
Number of subjects: 0
Study 11925400 — intervention group
Group type: COMPARATOR
Intervention: Cleaving embryo transfer
Number of subjects: 0
Study 9928752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg
Number of subjects: 51
Study 9928752 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 51
Study 8775070 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL) for lower caliceal stones
Number of subjects: 219
Study 2197095 — intervention group
Group type: EXPERIMENTAL
Intervention: Björk-Shiley (BS) prosthesis
Number of subjects: 178
Study 2197095 — intervention group
Group type: COMPARATOR
Intervention: St Jude Medical (SJM) prosthesis
Number of subjects: 178
Study 508687 — intervention group
Group type: EXPERIMENTAL
Intervention: Scatter xenon arc panretinal photocoagulation (15 eyes)
Number of subjects: 33
Study 508687 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment group (19 eyes)
Number of subjects: 33
Study 30306670 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation programme (VRP)
Number of subjects: 47
Study 30306670 — intervention group
Group type: COMPARATOR
Intervention: General physical exercise (Control Group)
Number of subjects: 47
Study 28865890 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-proANP
Number of subjects: 102
Study 28865890 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 102
Study 28865890 — intervention group
Group type: EXPERIMENTAL
Intervention: AF burden categories (0%, 0% to 99%, and 99% to 100%)
Number of subjects: 102
Study 28865890 — intervention group
Group type: COMPARATOR
Intervention: Baseline propeptide concentrations
Number of subjects: 102
Study 26228394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 78
Study 26228394 — intervention group
Group type: COMPARATOR
Intervention: Computer games control activities
Number of subjects: 78
Study 23444161 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary dentures with full palatal coverage (Group I, n = 10)
Number of subjects: 19
Study 23444161 — intervention group
Group type: COMPARATOR
Intervention: Maxillary dentures with partial palatal coverage (Group II, n = 9)
Number of subjects: 19
Study 21502860 — intervention group
Group type: EXPERIMENTAL
Intervention: Seprafilm (hyaluronic acid-carboxymethylcellulose membrane)
Number of subjects: 71
Study 21502860 — intervention group
Group type: COMPARATOR
Intervention: Control (no Seprafilm)
Number of subjects: 71
Study 21502860 — intervention group
Group type: EXPERIMENTAL
Intervention: Seprafilm
Number of subjects: 71
Study 21502860 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study 21502860 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life questionnaires (VAS-pain score, EQ-5D, SF-36)
Number of subjects: 71
Study 19465422 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 329
Study 16759740 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgicept (70% ethanol, CHG, BZK, ethylhexylglycerin)
Number of subjects: 0
Study 16759740 — intervention group
Group type: COMPARATOR
Intervention: Avagard (61% ethanol, 1% CHG)
Number of subjects: 0
Study 15567095 — intervention group
Group type: EXPERIMENTAL
Intervention: V-1 Immunitor (V1) b.i.d.
Number of subjects: 47
Study 15567095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 11149033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine alone (2.5 micrograms/kg/min for 2 postoperative days)
Number of subjects: 40